BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27115569)

  • 1. Tubal ligation and incidence of 26 site-specific cancers in the Million Women Study.
    Gaitskell K; Coffey K; Green J; Pirie K; Reeves GK; Ahmed AA; Barnes I; Beral V
    Br J Cancer; 2016 Apr; 114(9):1033-7. PubMed ID: 27115569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tubal ligation and ovarian cancer risk in a large cohort: Substantial variation by histological type.
    Gaitskell K; Green J; Pirie K; Reeves G; Beral V;
    Int J Cancer; 2016 Mar; 138(5):1076-84. PubMed ID: 26378908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of tubal ligation on the incidence of epithelial cancer of the ovary.
    Koch M; Starreveld AA; Hill GB; Jenkins H
    Cancer Detect Prev; 1984; 7(4):241-5. PubMed ID: 6488215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No. 344-Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal Cancer in the General Population.
    Salvador S; Scott S; Francis JA; Agrawal A; Giede C
    J Obstet Gynaecol Can; 2017 Jun; 39(6):480-493. PubMed ID: 28527613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometriosis and the development of tuboperitoneal fistulas after tubal ligation.
    Rock JA; Parmley TH; King TM; Laufe LE; Su BS
    Fertil Steril; 1981 Jan; 35(1):16-20. PubMed ID: 7461150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tubal polyps, epithelial inclusions, and endometriosis after tubal sterilization.
    Donnez J; Casanas-Roux F; Ferin J; Thomas K
    Fertil Steril; 1984 Apr; 41(4):564-8. PubMed ID: 6705932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of epithelial ovarian cancer Type I and II after hysterectomy, salpingectomy and tubal ligation-A nationwide case-control study.
    Darelius A; Kristjansdottir B; Dahm-Kähler P; Strandell A
    Int J Cancer; 2021 Oct; 149(8):1544-1552. PubMed ID: 34152012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian cancer risk factors by tumor dominance, a surrogate for cell of origin.
    Kotsopoulos J; Terry KL; Poole EM; Rosner B; Murphy MA; Hecht JL; Crum CP; Missmer SA; Cramer DW; Tworoger SS
    Int J Cancer; 2013 Aug; 133(3):730-9. PubMed ID: 23364849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies.
    Sieh W; Salvador S; McGuire V; Weber RP; Terry KL; Rossing MA; Risch H; Wu AH; Webb PM; Moysich K; Doherty JA; Felberg A; Miller D; Jordan SJ; ; ; Goodman MT; Lurie G; Chang-Claude J; Rudolph A; Kjær SK; Jensen A; Høgdall E; Bandera EV; Olson SH; King MG; Rodriguez-Rodriguez L; Kiemeney LA; Marees T; Massuger LF; van Altena AM; Ness RB; Cramer DW; Pike MC; Pearce CL; Berchuck A; Schildkraut JM; Whittemore AS;
    Int J Epidemiol; 2013 Apr; 42(2):579-89. PubMed ID: 23569193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tubal ligation and the risk of ovarian carcinoma.
    Cornelison TL; Natarajan N; Piver MS; Mettlin CJ
    Cancer Detect Prev; 1997; 21(1):1-6. PubMed ID: 9043756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serous ovarian, fallopian tube and primary peritoneal cancers: a comparative epidemiological analysis.
    Jordan SJ; Green AC; Whiteman DC; Moore SP; Bain CJ; Gertig DM; Webb PM; ;
    Int J Cancer; 2008 Apr; 122(7):1598-603. PubMed ID: 18058817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenocarcinoma of the bilateral fallopian tube occurring after tubal sterilization.
    Toki T; Imai T; Kobayashi H; Oguchi O; Silverberg SG; Fujii S
    Gynecol Oncol; 1995 Sep; 58(3):400-3. PubMed ID: 7672711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian Cancer Risk Factor Associations by Primary Anatomic Site: The Ovarian Cancer Cohort Consortium.
    Fortner RT; Rice MS; Knutsen SF; Orlich MJ; Visvanathan K; Patel AV; Gaudet MM; Tjønneland A; Kvaskoff M; Kaaks R; Trichopolou A; Pala V; Onland-Moret NC; Gram IT; Amiano P; Idahl A; Allen NE; Weiderpass E; Poynter JN; Robien K; Giles GG; Milne RL; Setiawan VW; Merritt MA; van den Brandt PA; Zeleniuch-Jacquotte A; Arslan AA; O'Brien KM; Sandler DP; Wolk A; Håkansson N; Harris HR; Trabert B; Wentzensen N; Tworoger SS; Schouten LJ
    Cancer Epidemiol Biomarkers Prev; 2020 Oct; 29(10):2010-2018. PubMed ID: 32732252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tubal ligation in relation to menopausal symptoms and breast cancer risk.
    Nichols HB; Baird DD; DeRoo LA; Kissling GE; Sandler DP
    Br J Cancer; 2013 Sep; 109(5):1291-5. PubMed ID: 23922107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of opportunistic salpingectomy vs tubal ligation at the time of cesarean delivery.
    Venkatesh KK; Clark LH; Stamilio DM
    Am J Obstet Gynecol; 2019 Jan; 220(1):106.e1-106.e10. PubMed ID: 30170036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tubal Ligation Induces Quiescence in the Epithelia of the Fallopian Tube Fimbria.
    Tiourin E; Velasco VS; Rosales MA; Sullivan PS; Janzen DM; Memarzadeh S
    Reprod Sci; 2015 Oct; 22(10):1262-71. PubMed ID: 25736327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of ovarian cancer after salpingectomy and tubal ligation: Prospects on histology and time since the procedure.
    Duus AH; Zheng G; Baandrup L; Faber MT; Kjær SK
    Gynecol Oncol; 2023 Oct; 177():125-131. PubMed ID: 37683548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personal and environmental characteristics related to epithelial ovarian cancer. II. Exposures to talcum powder, tobacco, alcohol, and coffee.
    Whittemore AS; Wu ML; Paffenbarger RS; Sarles DL; Kampert JB; Grosser S; Jung DL; Ballon S; Hendrickson M
    Am J Epidemiol; 1988 Dec; 128(6):1228-40. PubMed ID: 3195564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hysteroscopic tubal sterilization: an evidence-based analysis.
    McMartin K
    Ont Health Technol Assess Ser; 2013; 13(21):1-35. PubMed ID: 24228084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.
    Finch A; Beiner M; Lubinski J; Lynch HT; Moller P; Rosen B; Murphy J; Ghadirian P; Friedman E; Foulkes WD; Kim-Sing C; Wagner T; Tung N; Couch F; Stoppa-Lyonnet D; Ainsworth P; Daly M; Pasini B; Gershoni-Baruch R; Eng C; Olopade OI; McLennan J; Karlan B; Weitzel J; Sun P; Narod SA;
    JAMA; 2006 Jul; 296(2):185-92. PubMed ID: 16835424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.